《半日總結》恆指升412點 車股揚 舜宇漲逾6%
美聯儲局主席鮑威爾放「鴿」指不會因擔心可能出現通脹而先發制人地加息。美國股市昨晚(22日)造好，納指創收市新高升0.8%。港股早市隨外圍造好，恆指今早高開158點後升勢持續，近午市升幅擴大，最多升452點一度高見28,762點，半日升412點或1.5%，報28,721點；國指升149點或1.4%，報10,619點。恆生科技指數升146點或1.9%，報7,958點。港股半日成交808.38億元。滬、深港通南下交易半日分別錄得淨流入9.4億元及10.29億元人民幣。
科技股表現向好，騰訊(00700.HK)今早回升，半日升1.1%報580元。美團(03690.HK)重上300元，升4.2%報305元。舜宇光學(02382.HK)更升6.6%，銀河-聯昌證券引述舜宇管理層料受惠行業發展，料車載頭增長將加快；小米(01810.HK)、阿裏巴巴(09988.HK)及京東(09618.HK)分別升0.2%、11.9%及2.6%
部分汽車股急升，吉利汽車(00175.HK)半日彈高7.4%，爲表現最佳藍籌股，比亞迪(01211.HK)亦升4.3%；長城汽車(02333.HK)升7.6%，券商大和引述長汽指內地政府投放原料國儲助成本回穩，料盈利能力好轉。東風集團(00489.HK)及五菱汽車(00305.HK)升0.8%及2.1%。
友邦保險(01299.HK)獲批開始籌建湖北分公司，早市股價升1.9%。匯控(00005.HK)微升0.2%，造45.85元。港交所(00388.HK)升1.8%。中移動(00941.HK)跌0.4%。
內銀股靠穩，國壽(02628.HK)、工行(01398.HK)、建行(00939.HK)升0.8%、0.2及0.3%。中石油(00857.HK)續升2.5%。
內地將新冠疫苗產品列入可供對外出口新冠病毒疫苗產品清單，生物科技股造好，康希諾(06185.HK)今早漲逾一成後中途停牌；藥明生物(02269.HK)升4.4%，康龍化成(03759.HK)升2.3%，德琪醫藥(06996.HK)飆17.4%。
體育用品股續升，安踏體育(02020.HK)及特步(01368.HK)股價均升逾3%，李寧(02331.HK)亦升2.2%。
海底撈(06862.HK)則跌3.5%，呷哺呷哺(00520.HK)及頤海國際(01579.HK)分別跌1.9%及1.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
